Literature DB >> 23984257

Prayer sign.

Sujeet Raina1, Ajay Jaryal, Tushar Sonnatakke.   

Abstract

Entities:  

Year:  2013        PMID: 23984257      PMCID: PMC3752499          DOI: 10.4103/2229-5178.115545

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN: 2229-5178


× No keyword cloud information.
A 50-year-old male with poorly controlled type 2 diabetes of 10 years duration presented with history of inability to straighten his fingers. Microvascular complications in the form of retinopathy, neuropathy and nephropathy were present. Examination of hands revealed presence of “Prayer sign,” a feature of diabetic cheiroarthropathy [Figure 1]. It is also known as diabetic stiff hand syndrome or limited joint mobility syndrome. It is found in both type 1 and type 2 diabetic patients. The prevalence increases with duration of diabetes.[1] This condition is associated with and predictive of diabetic microvascular complications. Increased glycosylation of collagen in the skin and periarticular tissue, increased collagen degradation, microangiopathy and neuropathy are postulated to be the multiple factors responsible for it. Biopsy specimens of involved skin show pronounced thickening of periarticular collagen. Treatment consists of achieving gIycemic control and an individualized hand therapy programme.[2]
Figure 1

The “prayer sign” is shown by inability to completely close gaps between the opposed palms and fingers on pressing them together

The “prayer sign” is shown by inability to completely close gaps between the opposed palms and fingers on pressing them together
  1 in total

Review 1.  Musculoskeletal manifestations of diabetes mellitus.

Authors:  L L Smith; S P Burnet; J D McNeil
Journal:  Br J Sports Med       Date:  2003-02       Impact factor: 13.800

  1 in total
  1 in total

1.  Evaluation of limited hand mobility in systemic sclerosis patients by using "prayer sign" and "tabletop sign".

Authors:  Sadettin Uslu; Semih Gülle; Gerçek Can; İsmail Sarı; Fatoş Önen; Merih Birlik
Journal:  Clin Rheumatol       Date:  2021-02-08       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.